Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Arterial cannula improves cardiac patient safety

CardiacAssist : 12 September, 2013  (New Product)
With over-insertion prevention technology and secure attachment features, the Protek17 arterial cannula improves comfort and safety for severe cardiac dysfunction patients
Arterial cannula improves cardiac patient safety


CardiacAssist has announced the launch of the Protek17 Arterial Cannula, a key component of the TandemHeart temporary circulatory support platform used to rest the heart and circulate blood for patients with severe cardiac dysfunction. Protek17 is designed for improved patient safety and ease of use, with new features including suture wings for secure attachment to the patient and a rubber stop to prevent over-insertion, a common cause of vascular access site bleeding.



“The Protek17 cannula represents a major milestone for our company and is the first in a family of products we plan to launch in the near future,” said John Marous, President & CEO of CardiacAssist. “We will continue to focus on new product development and the advancement of clinical science to improve the quality of circulatory support therapy across a wide spectrum of patient needs.”



The Protek17 cannula is FDA-cleared and has been successfully deployed in multiple TandemHeart cases during a limited commercial release in 2013, and it is now available for full commercial distribution.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo